Skip to main content
Fig. 3 | European Journal of Medical Research

Fig. 3

From: Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathway

Fig. 3

Network pharmacological analysis predicted GPS targets and pathways affecting GC. A Predicting the intersection of targets of action of GPS. B Venn diagram of the cross-targets associated with the target of GC and the target of GPS. C PPI network of Gentianoside on GC targets. D List of hub genes for GPS on GC by degree method. E Analysis of KEGG enrichment of GC target genes by GPS. F Molecular docking analyses of the three-dimensional structure of GPS and EGFR

Back to article page